,
Fisher, Jacqueline Horan
Becan, Jennifer E.
Harris, Philip W.
Nager, Alexis
Baird-Thomas, Connie
Hogue, Aaron
Bartkowski, John P.
Wiley, Tisha
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA036221, U01DA036226, U01DA036233, U01DA036176, U01DA036225, U01DA036224, U01DA036158)
Article History
Received: 2 January 2018
Accepted: 26 March 2018
First Online: 30 April 2018
Ethics approval and consent to participate
: Ethic approval was granted by the Institutional Review Boards (IRB) of Texas Christian University (#1410–106-1411), University of Kentucky, Mississippi State University (#13–205), Emory University (#77541), Columbia University (#6765), and Temple University (#22451). All aspects of the research study were explained to all participants and informed consent was obtained, in concordance with the IRB protocols at each of these research centers.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.